miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway.

Liu, Yawei; Hu, Litian; Liu, Qinqiang; Ye, Jing; Zhang, Jianping

Liu, Yawei; Hu, Litian; Liu, Qinqiang; Ye, Jing; Zhang, Jianping.

Afiliación

Liu Y; Department of General Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China.
Hu L; Department of General Surgery, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Liu Q; Department of General Surgery, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Ye J; Department of General Surgery, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Zhang J; Department of General Surgery, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

J Oncol ; 2022: 5744999, 2022.

Article en En | MEDLINE | ID: mdl-36245984

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Egipto

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google